AMR Control 2017



05 Introduction Jean Carlet PDF  Online 



08 Responses to antimicrobial resistance in all policies – the German AMR strategy Karin Knufmann-Happe, Director General for Health Protection, Disease Control and  Biomedicine, Federal Ministry of Health, Germany PDF  Online 

12 Governance against antimicrobial resistance in Africa: Confronting AMR when resources are limited – the example of Senegal Professor Awa Marie Coll-Seck, Minister of Health and Social Action, Republic of Senegal; Professor Ibrahima Seck, Technical Adviser to the Minister of Health and Social Action, Republic of Senegal; Professor Ahmad Lyane Sow, Director of Laboratories, Ministry of Health and Social Action, Republic of Senegal; Professor Babacar Ndoye, Former Coordinator of Pronalin; Dr Mamadou Ngom, Pharmacist, WHO/Senegal Focal Point for Laboratories and Medicines, and Dr Pape Amadou Diack, Director General of Health, Ministry of Health and Social Action, Republic of Senegal.  PDF  Online 

17 A national action plan to contain antimicrobial resistance in China: Contents, actions and expectations Professor Yonghong Xiao, Vice-Director, State Key Laboratory for Diagnosis & Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China PDF  Online 

21 Antibiotic resistance in Lebanon Professor Pascale Salameh, Professor of Epidemiology, Faculty of Pharmacy & Faculty of Medicine, Lebanese University, Hadath, Lebanon; Dr Hala Sacre, Director, Drug Information Center, Lebanese Order of Pharmacists, Beirut, Lebanon; Dr Souheil Hallit, Director of the Research Department, Psychiatric Hospital of the Cross, Jal Eddib, Lebanon and Assistant Professor Aline Hajj, Laboratory of Pharmacology, Clinical Pharmacy and Quality Control of Drugs, Faculty of Pharmacy, Saint-Joseph University, Beirut, Lebanon  PDF  Online 

28 Combining the fight against antimicrobial resistance with access to medicines: The case of the African region Professor Smail Mesbah Director General of Prevention and Health Promotion, Ministry of Health, Algeria  PDF  Online 

29 On the value of viewing AMR as a threat to international security Associate Professor Adam Kamradt-Scott, Centre for International Security Studies, Associate Professor Dale Dominey-Howes, School of Geosciences, University of Sydney, Sydney, Australia and Dr Maurizio Labbate, Senior Lecturer, School of Life Sciences, University of Technology Sydney, Australia  PDF  Online 


One Health

34 The unique contribution of One Health to combating antibiotic resistance Dr Steven L Solomon Director, Global Public Health Consulting, Georgia, USA PDF   Online 

39 The OIE commitment to overcoming antimicrobial resistance and why it is important Dr Elisabeth Erlacher-Vindel,  Head of Science and New Technologies Department at the World Organisation for Animal Health (OIE); Professor Jacques Acar, Senior Expert, World Organisation for Animal Health (OIE) and Professor Emeritus of Clinical Microbiology and Infectious Diseases, Pierre and Marie Curie University and Dr Margot Raicek, Chargée de Mission, Science and New Technologies Department at the World Organisation for Animal Health (OIE) PDF  Online 

44 Agriculture and food production as drivers of the global emergence and dissemination of antimicrobial resistance Professor Ellen Silbergeld, Johns Hopkins University, Bloomberg School of Public Health, USA; Dr Awa Aidara-Kane, Coordinator WHO–AGISAR and Jennifer Dailey, PhD student in materials science and engineering, Johns Hopkins University, USA PDF  Online 

50 Prevention first: Tackling antimicrobial resistance through water, sanitation and hygiene Alison Macintyre, Health Advisor, WaterAid Australia; Megan Wilson-Jones, Policy Analyst on Health and Hygiene, WaterAid UK and Yael Velleman, Senior Policy Analyst on Health and Hygiene, WaterAid UK PDF  Online 

55 The ESBL tricycle antimicrobial resistance surveillance project: A simple, One Health approach to global surveillance Jorge Matheu and Dr Awa Aidara-Kane, WHO Food Safety and Zoonoses Department, Geneva, Switzerland; and Professor Antoine Andremont, University Paris-Diderot Medical School, Paris, France PDF  Online 



60 Drug-resistant tuberculosis: what is the situation, what are the needs to roll it back? Dr Karin Weyer, Coordinator, laboratories, diagnostics and drug resistance; Dr Dennis Falzon, Medical Officer; Dr Ernesto Jaramillo, Team Leader, Drug-resistant TB policies; Dr Matteo Zignol, Team Lead, Global Project on Anti-Tuberculosis drug resistance surveillance; Dr Fuad Mirzayev, Team Lead, Policy Transfer and Uptake and Professor Mario Raviglione, Director, Global TB Programme, World Health Organization, Switzerland PDF  Online 

68  Sponsored Feature

The global point prevalence survey – biomérieux and Antwerp University renew their commitment to combat antimicrobial resistance Isabelle Caniaux, bioMérieux, France; Ann Versporten, Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, Faculty of Medicine and Health Science, University of Antwerp,  Belgium; Christine Micolaud, bioMérieux, USA; Marie Françoise Gros and Mark Miller, bioMérieux, France and Herman Goossens, Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, Faculty of Medicine and Health Science, University of Antwerp, Belgium PDF  Online 

70 Intensive care units as epicentres for antimicrobial resistance development Dr Jean Carlet President, WAAAR and Professor Jan De Waele, Intensivist, Ghent University Hospital, Belgium PDF  Online 

75 Improving rational antibiotic treatment of common childhood conditions in Uganda Dr Tamar Chitashvili, Senior Improvement Advisor, University Research Co, LLC, Uganda; Dr Ekaterine Cherkezishvili, Research Consultant, University Research Co, LLC, Georgia; Dr Esther Karamagi, and Dr Nicholas Mwanja, University Research Co, LLC, Uganda PDF  Online 

82 Sponsored Feature

Less than one cent to save a patient from AMR? Rajiv Nath, HMD, India, is the Forum Coordinator of AiMeD – Association of the Indian Medical Device Industry PDF  Online 

83 Infections in surgery – a key battleground to combat antimicrobial resistance Dr Massimo Sartelli, Consultant surgeon, Macerata Hospital, Italy, and founder of the Global Alliance for Infections in Surgery PDF  Online 


86 Sponsored Feature

Because taking care is the  essence of healthcare Fabienne Ostermeyer, International Development Director, Visiomed Group International PDF  Online 

88 Potential impact of telemonitoring by connected devices on the evaluation of antibiotic therapy’s duration in the ambulatory treatment of pulmonary infections Dr Aurélien Dinh, Infectious Disease Specialist and Clara Duran, Clinical Research Associate, Infectious Disease Unit, Raymond Poincaré Teaching Hospital, Versailles Saint-Quentin University, France; and Dr François Teboul, Emergency MD and Medical Director for Visiomed, Paris, France PDF  Online 

93 Using quality improvement to address hospital-acquired infections and antimicrobial resistance  Leighann E Kimble, Healthcare Improvement Fellow, Quality & Performance Institute, University Research Co, LLC, USAID Applying Science to Strengthen and Improve Systems (ASSIST) Project; Dr M Rashad Massoud, Chief Medical and Quality Officer/Senior Vice President, Quality & Performance Institute, University Research Co, LLC, Director USAID  ASSIST Project and Dr James Heiby, Medical Officer, US Agency for International Development, Bureau for Global Health, Office of Health Systems PDF  Online 

96 Embedding quality improvement through a learning collaborative to reduce and sustain hospital-acquired infections in the West Bank Abed Alra’oof Saleem, Director, Quality Planning Department, Ministry of Health, Palestine; Dr Musa Hindiyeh, Director of Caritas Baby Hospital Clinical Laboratory, Bethlehem; Dr Ali Ahmed Sabateen, Head, ID Unit, Augusta Victoria Hospital, East Jerusalem; Dina Nasser, Nurse; Dr Rabee S A Adwan, Al Makassed Hospital, East Jerusalem; Lisa Dolan-Branton, Senior Improvement Advisor, USAID; Jennifer Ross, Lecturer, Robert Gordon University, Aberdeen UK, Ghazaleh Samandari and Sarah Kauder, Improvement Specialist, USAID ASSIST PDF  Online 


Economics and Innovation

100 Containing antimicrobial resistance is a smart investment in global public health and wealth Dr Eni̇s Bariş, Practice Manager, Health, Nutrition and Population Global Practice, World Bank; Alexander Irwin, Consultant, Health, Nutrition and Population Global Practice, World Bank; Alessia Thiebaud, Research Analyst, Health, Nutrition and Population Global Practice, World Bank and Dr Timothy Grant Evans, Senior Director, Health, Nutrition and Population Global Practice, World Bank PDF  Online  

106 Sponsored Feature

We have the tools to tackle AMR – let’s use them Serge Bernasconi, MedTech Europe PDF  Online 


107 Socioeconomics, antimicrobial use and antimicrobial resistance Molly Miller-Petrie Research Associate, CDDEP and Hellen Gelband, Associate Director for Policy, CDDEP PDF  Online 

113 The Economics of reducing antibiotic use to reduce antimicrobial resistance Dr Edward I Broughton Director of Research and Evaluation, Q&P Institute, USAID ASSIST URC, USA PDF  Online 

117 The role of the Biomedical Advanced Research and Development Authority (BARDA) in promoting innovation in antibacterial product development Dr Christopher Houchens, Branch Chief, Antibacterial Program and Dr Joe Larsen Deputy Director, Division of CBRN Medical Countermeasures, Biomedical Advanced Research and Development Authority, Office of Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington DC, USA  PDF  Online 


Alternatives to Antibiotics

122 Research in essential oils:  The case of oregano  Assistant Professor, Nora Mahfouf Faculty of Science, University of Chadly Ben Djedid, Algeria PDF  Online 

124 The Brazilian Peppertree: An old cure for new wounds Dr Cassandra L Quave Assistant Professor of Dermatology and Human Health, Emory University, USA PDF  Online 


125 Apendix 1: WAAAR PDF  Online 

127 Apendix 2: CARA PDF  Online